Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
4.360
-0.190 (-4.18%)
Mar 31, 2025, 10:51 AM EDT - Market open

Company Description

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States.

The company operates in two segments, Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics.

The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies.

It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, ACOs, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities.

The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017.

Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Health Catalyst, Inc.
Health Catalyst logo
Country United States
Founded 2008
IPO Date Jul 25, 2019
Industry Health Information Services
Sector Healthcare
Employees 1,500
CEO Daniel Burton

Contact Details

Address:
10897 South River Front Parkway, Suite 300
South Jordan, Utah 84095
United States
Phone (801) 708-6800
Website healthcatalyst.com

Stock Details

Ticker Symbol HCAT
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $26.00
CIK Code 0001636422
CUSIP Number 42225T107
ISIN Number US42225T1079
Employer ID 45-3337483
SIC Code 7370

Key Executives

Name Position
Daniel D. Burton Chief Executive Officer and Director
Jason Alger Chief Financial Officer
Benjamin Landry General Counsel and Secretary of the Board
Linda Llewelyn Chief People Officer
Daniel LeSueur Chief Operating Officer
Dave Ross Chief Technology Officer
Amanda Flanders Senior Vice President of Marketing and Communications
Kyle J. Salyers Chief Strategy Officer and Senior Vice President of Corporate Development
Jeffrey P. Selander Senior Vice President of International
Holly Rimmasch Senior Vice President and Chief Clinical Officer

Latest SEC Filings

Date Type Title
Mar 6, 2025 144 Filing
Mar 5, 2025 144 Filing
Mar 3, 2025 144 Filing
Mar 3, 2025 144 Filing
Mar 3, 2025 144 Filing
Mar 3, 2025 144 Filing
Mar 3, 2025 144 Filing
Mar 3, 2025 144 Filing
Feb 26, 2025 S-8 Securities to be offered to employees in employee benefit plans
Feb 26, 2025 10-K Annual Report